688359.SH
三孚新科
SSE · Basic Materials · Chemicals - Specialty · CN
CNY 94.58
−1.46%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 490.1M | 457.9M | 621.3M | 497.4M | 364.6M |
| Cost of Revenue | 337.1M | 292.0M | 383.4M | 337.4M | 255.7M |
| Gross Profit | 153.0M | 165.8M | 237.8M | 160.0M | 108.9M |
| Operating Expenses | |||||
| R&D Expense | 64.1M | 67.2M | 73.1M | 50.6M | 28.7M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 70.3M | 75.4M | 108.4M | 100.4M | 90.8M |
| Selling & Marketing Expense | 68.7M | 67.4M | 50.7M | 38.2M | 27.7M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 218.6M | 225.7M | 250.3M | 201.3M | 150.3M |
| Cost and Expenses | 555.7M | 517.8M | 633.7M | 538.7M | 406.0M |
| Operating Income (EBIT) | (76.8M) | (78.8M) | (2.5M) | (45.8M) | (46.0M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (77.2M) | (79.1M) | (2.6M) | (45.8M) | (48.1M) |
| Income Tax Expense | (11.8M) | (18.5M) | (7.0M) | (11.0M) | (11.6M) |
| Bottom Line | |||||
| Net Income | (48.2M) | (48.3M) | (12.6M) | (36.8M) | (32.2M) |
| Earnings from Cont. Ops | (65.4M) | (60.5M) | 4.4M | (34.8M) | (36.5M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (48.2M) | (48.3M) | (12.6M) | (36.8M) | (32.2M) |
| Per Share | |||||
| Basic EPS | (CN¥0.49) | (CN¥0.50) | (CN¥0.14) | (CN¥0.40) | (CN¥0.35) |
| Diluted EPS | (CN¥0.49) | (CN¥0.50) | (CN¥0.14) | (CN¥0.40) | (CN¥0.35) |
| Revenue Per Share | CN¥5.28 | CN¥4.74 | CN¥6.91 | CN¥5.41 | CN¥3.96 |
| Shares | |||||
| Basic Shares Outstanding | 92.8M | 96.6M | 89.9M | 92.0M | 92.1M |
| Diluted Shares Outstanding | 92.8M | 96.6M | 89.9M | 92.0M | 92.1M |
| Profitability Metrics | |||||
| EBITDA | — | (37.2M) | 42.0M | (13.4M) | (38.0M) |
| D&A | — | 41.6M | 44.5M | 32.4M | 8.1M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026